Abstract
Intrathecal drug delivery (ITDD) systems are a safe and effective interventional therapy for chronic pain that is refractory to oral pharmacologic therapy. However, safely discontinuing ITDD of opioid medications without precipitating withdrawal symptoms have not been well documented, nor does any established protocol exist.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Paper Title
Journal
Date
